Human disease models

Pluripotent stem cells
#Human disease models #iPSC #Liver disease #Preclinical investigations #Stem cells #Webinar

Discover how iPSC derived cells can be used to support the development of drug and gene therapies

A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may have limited success in replicating liver diseases, primarily because of species-specific differences, furthermore, the utilisation of animal models to simulate… Read More

Webinar date:
Supported by DefiniGEN
#Webinars

Microscopic image of brain organoids tissue
#Human disease models #Neurodegenerative disorders #Neurology #Organoids #University of Michigan

Researchers create human brain organoids without animal cells

Researchers at University of Michigan (U-M) have developed a method to produce human brain organoids without animal cells that could improve the way neurodegenerative conditions are studied and treated. Human brain organoids are derived from embryonic or pluripotent stem cells and more closely model the complex… Read More

#News

Medical researchers
#Human disease models #Humanised Immune System (HIS) #Stem cells #The Jackson Laboratory

Which immune-humanized platform is right for my application?

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

#Charles River #Drug discovery #Gene therapy #Human disease models #Immunotherapy #iPSC #Regenerative Medicine #Stem cells

Stem cells’ versatility in drug development  

This article is sponsored by Charles River. Research tools, safety testing and regenerative medicines – these endless stem cell applications are powering precision, speed, and new modalities in drug development.     Stem cells for use in drug discovery Stem cells are fast becoming an invaluable tool in the drug… Read More

#News

Scientist in laboratory
#Human disease models #Humanised Immune System (HIS) #Stem cells #The Jackson Laboratory

Webinar: How to choose the right immune-humanized platform

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

Scientist in laboratory
#Human disease models #Humanised Immune System (HIS) #Stem cells #The Jackson Laboratory

Exclusive event: How to compare immune-humanized platforms

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

Female scientist looking through microscope
#Human disease models #Humanised Immune System (HIS) #Stem cells #The Jackson Laboratory

Which immune-humanized platform is best for your application?

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

Laboratory equipment
#Human disease models #Humanised Immune System (HIS) #Stem cells #The Jackson Laboratory

Which immune-humanized platform is best for my application?

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate… Read More

Webinar date:
Brought to you by The Jackson Laboratory
#News

Laboratory equipment
#Human disease models #Humanised Immune System (HIS) #Stem cells #The Jackson Laboratory

Comparing immune-humanized platforms: Which one is best for my application?

Humanization of highly immunodeficient NSG mice with hematopoietic stem cells or peripheral blood mononuclear cells provides a powerful platform for very precise modeling of human immune responses. These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function. Read More

Webinar date:
Brought to you by The Jackson Laboratory
#Webinars

Cancer Research UK Beatson Institute
#Animal models #Cancer research #Cancer Research UK #Cancer Research UK Beatson Institute #ELRIG #Events #Human disease models #Scotland #University of Glasgow

Scottish drug discovery: Advancing new research models

Following the Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provides a snapshot of drug discovery in Scotland. With over 150 pharma services/supply companies and 19 universities, Scotland is one of the most advanced life science sectors in the UK and the world. To demonstrate how Scotland is… Read More

#Exclusive Content

Animal testing
#Animal models #Animal testing #Cancer research #Human disease models #Oncology #Preclinical development

Closing the translation gap in oncology drug development

Jantzen Sperry, PhD, Director of Scientific Operations at Certis Oncology looks at how the adoption of orthotopic PDX models can elevate the impact of cancer research and improve translation in oncology drug development. The recent passage of the FDA Modernization Act, which removed the requirement for animal testing when suitable… Read More

#Cancer Research #Exclusive Content

Leukaemia
#AACR 2023 #Blood cancer #Cancer research #Human disease models #Oncology

Unique new models will empower leukaemia research

Tisch Cancer Center scientists have developed unique models of acute myeloid leukaemia (AML), creating a transformative resource to study this cancer and eventually its drug response and drug resistance. The research was presented at the annual meeting of the American Association of Cancer Research and simultaneously… Read More

#Cancer Research #News

Neurons
#App note #Cell culture #Human disease models #In vivo #Live cell analysis #Sartorius

App Note: Kinetically quantify neuronal outgrowth

Monitoring neuronal morphology in long-term in vitro cell cultures is critical for characterisation and evaluation of disease models and to understand neuronal development. Ideally, approaches to track neurite dynamics would allow continuous automated measurements of structural parameters, including neurite length and number of branch points. These methods should be non-perturbing… Read More

#News

#App note #Cell culture #Human disease models #In vivo #Live cell analysis #Sartorius

Kinetically quantify neuronal outgrowth using live-cell analysis

Monitoring neuronal morphology in long-term in vitro cell cultures is critical for characterisation and evaluation of disease models and to understand neuronal development. Ideally, approaches to track neurite dynamics would allow continuous automated measurements of structural parameters, including neurite length and number of branch points. These methods should be non-perturbing… Read More

#App Notes #Intelligence #Resources

#App note #Genetic profiling #Human disease models #Huntington's disease #Phenotyping

Using disease models to accelerate Huntington’s disease research

Currently, no effective cure or treatment for Huntington’s disease exists. To accelerate Huntington’s disease research and drug discovery, researchers need access to physiologically relevant human disease models that recapitulate patient phenotypes, in combination with more advanced methods to understand the underlying mechanisms of the disease. Download this… Read More

#News

#App note #Genetic profiling #Human disease models #Huntington's disease #Phenotyping

Characterising the phenotype of an isogenic, human iPSC-derived Huntington’s disease model by MEA

Currently, no effective cure or treatment for Huntington’s disease exists. To accelerate Huntington’s disease research and drug discovery, researchers need access to physiologically relevant human disease models that recapitulate patient phenotypes, in combination with more advanced methods to understand the underlying mechanisms of the disease. In this App Note you… Read More

#App Notes #Intelligence #Resources